Alyeska Investment Group, L.P.

Q2 2015 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Jason Bragg - Chief Financial Officer
Location
Chicago, IL
Holdings as of
30 Jun 2015
Value $
$191,022,000
Num holdings
9
Filing time
19 Nov 2015, 09:53:48 UTC
Form type
13F-HR/A-2 - New Holdings
Description
Top holdings included OCR, HSP, HCBK, HME, and TRAK. Request for Confidential Treatment (14 Aug 2015): Confidential Treatment Expired on 16 Nov 2015.
Previous filing
Q1 2015 - 15 May 2015
Next filing
Q3 2015 - 16 Nov 2015
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Aug 2015 pursuant to a request for confidential treatment and for which confidential treatment expired on 16 Nov 2015.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Jason Bragg Chief Financial Officer Chicago, Illinois 19 Nov 2015

Other Included Managers (2):

Num Name Location File Number
1 Alyeska Master Fund, L.P. Chicago, IL 028-13417
2 Alyeska Master Fund 2, L.P. Chicago, IL 028-16151